Solving access challenges through unrivaled expertise combining strategic mindsets with strong technical capabilities

Pricing & Market Access strategy

We assess the opportunity of setting up an Early Access program in France

  • Situation analysis & benchmarking
  • Product positioning / value perception
  • Roadmap

Operational support

  • Assistance & support for the preparation
    of pre-submission meeting
  • Development of Early Access dossier
  • Facilitation of KOL advisory Board
  • Deployment

We outline the HTA potential of your drug

  • Clinical data analysis & KOL interviews
  • Benchmarking of relevant analogues
  • Expected challenges & opportunities

Operational support

  • Development of HAS dossiers
  • Facilitation of Market Access Advisory Boards
  • Assistance throughout the whole HTA process (pre-meeting, hearing…)

We set up your optimal pricing strategy

  • Audit of pricing strategy
  • Achievable price conditions (list/net)
  • Sequencing of price negotiation

Operational support

  • Development of CEPS dossier
  • Stakeholder mapping
  • Modeling of price agreements

We assist & guide you throughout the entire negotiation process until price publication

  • Adaptation of the pricing strategy
  • Strategic training & coaching

Operational support

  • Day-to-day support
  • Debrief meeting
  • Proposition of working documents based on CEPS offers

Why chooseAEC Partners ?

Extensive operational experience in rare diseases, oncology & ATMPs (Gene/cell therapies)

An experimented senior team dedicated to Market Access

More than 300 assignments supporting big, mid-size pharma & medical device companies with market access strategies in Europe